Medicine. The need for a global HIV vaccine enterprise
- PMID: 12829768
- DOI: 10.1126/science.1086916
Medicine. The need for a global HIV vaccine enterprise
Abstract
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to increase the pace, reduce the overlap, and more systematically explore the elements of and delivery systems for vaccines; (iii) to use common standards for the prompt comparative testing of vaccine candidates; (iv) to expand resources for manufacturing vaccine candidates to speed their use in human trials; and (v) to increase the capacity for international clinical trials and to focus this effort toward quickly measuring the effectiveness of vaccine protection as prototype vaccine candidates are identified.
Comment in
-
The challenges of an HIV vaccine enterprise.Science. 2004 Feb 27;303(5662):1294-7; author reply 1294-7. doi: 10.1126/science.303.5662.1294. Science. 2004. PMID: 14988536 No abstract available.
-
The challenges of an HIV vaccine enterprise.Science. 2004 Feb 27;303(5662):1294-7; author reply 1294-7. Science. 2004. PMID: 14991961 No abstract available.
Similar articles
-
The challenges of an HIV vaccine enterprise.Science. 2004 Feb 27;303(5662):1294-7; author reply 1294-7. Science. 2004. PMID: 14991961 No abstract available.
-
G-8 endorses new global HIV vaccine enterprise.Bull World Health Organ. 2004 Jul;82(7):557. Bull World Health Organ. 2004. PMID: 15500292 Free PMC article. No abstract available.
-
Funding support lacking in search for HIV vaccine.AIDS Alert. 1999 Jan;14(1):5-7. AIDS Alert. 1999. PMID: 11366091
-
The challenges of HIV vaccine development and testing.Best Pract Res Clin Obstet Gynaecol. 2005 Apr;19(2):277-91. doi: 10.1016/j.bpobgyn.2004.11.001. Best Pract Res Clin Obstet Gynaecol. 2005. PMID: 15778116 Review.
-
[Vaccines against HIV].Tidsskr Nor Laegeforen. 2006 Nov 30;126(23):3117-20. Tidsskr Nor Laegeforen. 2006. PMID: 17160118 Review. Norwegian.
Cited by
-
Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative.BMJ. 2004 Aug 21;329(7463):454-6. doi: 10.1136/bmj.329.7463.454. BMJ. 2004. PMID: 15321907 Free PMC article. Review.
-
Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques.J Virol. 2005 Jul;79(13):8131-41. doi: 10.1128/JVI.79.13.8131-8141.2005. J Virol. 2005. PMID: 15956558 Free PMC article.
-
Health and economic benefits of an accelerated program of research to combat global infectious diseases.CMAJ. 2004 Nov 9;171(10):1203-8. doi: 10.1503/cmaj.1041634. CMAJ. 2004. PMID: 15534314 Free PMC article. Review. No abstract available.
-
Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo.Gene Ther. 2010 Jan;17(1):37-49. doi: 10.1038/gt.2009.118. Epub 2009 Sep 10. Gene Ther. 2010. PMID: 19741733 Free PMC article.
-
Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.Springer Semin Immunopathol. 2006 Nov;28(3):289-301. doi: 10.1007/s00281-006-0026-3. Epub 2006 Sep 16. Springer Semin Immunopathol. 2006. PMID: 16983452 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical